'Incredible' Response Rates in Atopic Dermatitis With Drugs From China

(MedPage Today) — DENVER — Biological agents targeting interleukin-4 receptor alpha (IL-4Rα) in atopic dermatitis (AD) achieved rapid and substantial improvement in up to three-fourths of patients, according to randomized trials from China…